Comparative efficacy of biologics and small molecule drugs in treating pediatric atopic dermatitis in patients aged 2–18 years: A 12–16 week network meta‐analysis of randomized controlled trials
This analysis establishes a hierarchy of effectiveness among systemic therapies for pediatric AD, with upadacitinib showing highest efficacy. However, the predominance of adolescent data emphasizes the need for age-stratified studies in younger children and long-term safety assessments.
Authors
- Chang‐Ching Wei (ORCID: https://orcid.org/0000-0003-4835-3246)
- Xuan‐Yi Huang (ORCID: https://orcid.org/0000-0002-5446-7453)
- Berne Ting (ORCID: https://orcid.org/0000-0002-5752-082X)
- Li Jingling (ORCID: https://orcid.org/0000-0003-3843-3293)
- Jiu‐Yao Wang (ORCID: https://orcid.org/0000-0003-4540-9822)
- Su‐Boon Yong (ORCID: https://orcid.org/0000-0002-5175-908X)
- Ikbal Andrian Malau
- Suet‐Kei Wu (ORCID: https://orcid.org/0009-0007-0772-2742)
Institutions
- China Medical University (TW)
- China Medical University Hospital (TW)
- National Yang Ming Chiao Tung University (TW)
Publication Details
- Journal
- Pediatric Allergy and Immunology
- Published
- 2025-02-01
- DOI
- https://doi.org/10.1111/pai.70045
- Citations
- 5
- Primary Topic
- Dermatology and Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 10.02